Scribd
Upload
5 views

Conference

The document is an email containing a link to a conference document hosted on OneDrive. It includes HTML and CSS code for rendering the document in a web interface. The email was sent on April 5, 2025.

Uploaded by

bamaniakhushu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as TXT, PDF, TXT or read online on Scribd
5 views

Conference

The document is an email containing a link to a conference document hosted on OneDrive. It includes HTML and CSS code for rendering the document in a web interface. The email was sent on April 5, 2025.

Uploaded by

bamaniakhushu
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as TXT, PDF, TXT or read online on Scribd
You are on page 1/ 77

From: <Saved by Blink>

Snapshot-Content-Location:
https://onedrive.live.com/personal/196186043b33ed4e/_layouts/15/Doc.aspx?sourcedoc=
%7B7961b0dc-161a-48a8-8b44-
399f4a87c517%7D&action=default&redeem=aHR0cHM6Ly8xZHJ2Lm1zL3cvYy8xOTYxODYwNDNiMzNlZ
DRlL0VkeXdZWGthRnFoSWkwUTVuMHFIeFJjQkRmcWtfclVzSXd4cjJCLWdUSVVMLUE&slrid=437791a1-
b0ab-4000-f64e-
3a63054b458d&originalPath=aHR0cHM6Ly8xZHJ2Lm1zL3cvYy8xOTYxODYwNDNiMzNlZDRlL0VkeXdZW
GthRnFoSWkwUTVuMHFIeFJjQkRmcWtfclVzSXd4cjJCLWdUSVVMLUE_cnRpbWU9WWRRVlh5UjAzVWc&CID=
2cada497-bbe1-4299-a530-c4c49b92df67&_SRM=0:G:41
Subject: conference.docx
Date: Sat, 5 Apr 2025 09:30:03 -0000
MIME-Version: 1.0
Content-Type: multipart/related;
type="text/html";
boundary="----MultipartBoundary--
MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----"

------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/html
Content-ID: <[email protected]>
Content-Transfer-Encoding: binary
Content-Location:
https://onedrive.live.com/personal/196186043b33ed4e/_layouts/15/Doc.aspx?sourcedoc=
%7B7961b0dc-161a-48a8-8b44-
399f4a87c517%7D&action=default&redeem=aHR0cHM6Ly8xZHJ2Lm1zL3cvYy8xOTYxODYwNDNiMzNlZ
DRlL0VkeXdZWGthRnFoSWkwUTVuMHFIeFJjQkRmcWtfclVzSXd4cjJCLWdUSVVMLUE&slrid=437791a1-
b0ab-4000-f64e-
3a63054b458d&originalPath=aHR0cHM6Ly8xZHJ2Lm1zL3cvYy8xOTYxODYwNDNiMzNlZDRlL0VkeXdZW
GthRnFoSWkwUTVuMHFIeFJjQkRmcWtfclVzSXd4cjJCLWdUSVVMLUE_cnRpbWU9WWRRVlh5UjAzVWc&CID=
2cada497-bbe1-4299-a530-c4c49b92df67&_SRM=0:G:41

<!DOCTYPE html><html lang="en-us" dir="ltr"><head><meta http-equiv="Content-Type"


content="text/html; charset=UTF-8"><link rel="stylesheet" type="text/css"
href="cid:[email protected]" /><link
rel="stylesheet" type="text/css" href="cid:css-8f324af7-c663-46cd-b576-
[email protected]" /><link rel="stylesheet" type="text/css" href="cid:css-
[email protected]" />
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0,
maximum-scale=1.0, minimum-scale=1.0, user-scalable=no">
<meta name="robots" content="noindex">
<link
href="https://res-1.cdn.office.net/wise/owl/owl.slim.8601885bf94e22986316.js"
rel="preload" integrity="sha384-sW0XCCTcjtBnUgpyo2oQBmiPuWqHexm/cX/GXxgkZfO+oUeb/
k/T8KW+SDpCEztn" crossorigin="anonymous" as="script">
<link
href="https://res-1.cdn.office.net/wise/owl/word.boot.e9eff204f0cbdc1f1f48.js"
rel="preload"
integrity="sha384-4w0dqmdDg6H3g59hTrtOXtk1E4uSv/7JUuICK/5tS5j4JI6jlaYV5Z4rlyO4Yl3n"
crossorigin="anonymous" as="script">

<link rel="preconnect" href="https://word-edit.officeapps.live.com/">


<link rel="shortcut icon"
href="https://res-1.cdn.office.net/officeonline/wv/s/h4FBD8CC4075E1795_resources/
1033/FavIcon_Word.ico">
<title>conference.docx</title>

</head>
<body style="margin: 0; padding: 0; overflow: hidden; -ms-content-zooming: none">
<div id="WopiDocWACContainer" style="overflow: hidden"><div id="owl-
container" style="inset: 0px; height: 100%; width: 100%;"><iframe
id="WacFrame_Word_0" name="WacFrame_Word_0" src="cid:frame-
[email protected]" title="Office on the web Frame"
marginwidth="0" marginheight="0" frameborder="0" allowfullscreen="true"
allowtransparency="true" allow="microphone https://word-edit.officeapps.live.com;
autoplay https://word-edit.officeapps.live.com; camera https://word-
edit.officeapps.live.com; clipboard-read https://word-edit.officeapps.live.com;
clipboard-write https://word-edit.officeapps.live.com; keyboard-map https://word-
edit.officeapps.live.com; display-capture https://word-edit.officeapps.live.com"
style="inset: 0px; height: 100%; width: 100%; display: block; position: absolute;
background-color: transparent; border: none; visibility: visible;"></iframe><form
id="WacFrame_Word_0_Form" name="WacFrame_Word_0_Form" action="https://word-
edit.officeapps.live.com/we/wordeditorframe.aspx?ui=en-US&amp;rs=en-
US&amp;wopisrc=https%3A%2F%2Fptop.only.wip.la%3A443%2Fhttps%2Fmy.microsoftpersonalcontent.com%2Fpersonal
%2F196186043b33ed4e%2F_vti_bin%2Fwopi.ashx%2Ffiles
%2F7961b0dc161a48a88b44399f4a87c517&amp;sc=%7B%22pmo%22%3A%22https%3A%2F
%2Fonedrive.live.com%22%2C%22pmshare%22%3Atrue%2C%22redeem%22%3A
%22aHR0cHM6Ly8xZHJ2Lm1zL3cvYy8xOTYxODYwNDNiMzNlZDRlL0VkeXdZWGthRnFoSWkwUTVuMHFIeFJj
QkRmcWtfclVzSXd4cjJCLWdUSVVMLUE
%22%7D&amp;wdenableroaming=1&amp;mscc=0&amp;wdodb=1&amp;hid=587791A1-409E-4000-
EAB5-DBFDE43E707C.0&amp;uih=onedrivecom&amp;wdlcid=en-
US&amp;jsapi=1&amp;jsapiver=v2&amp;corrid=56351a54-dacc-e4a6-c2ea-
ff8ff766fd2b&amp;usid=56351a54-dacc-e4a6-c2ea-
ff8ff766fd2b&amp;newsession=1&amp;sftc=1&amp;uihit=docaspx&amp;muv=1&amp;cac=1&amp;
sams=1&amp;sfp=1&amp;sdp=1&amp;hch=1&amp;hwfh=1&amp;dchat=1&amp;ctp=LeastProtected&
amp;rct=Normal&amp;wdorigin=Sharing.ClientRedirect&amp;afdflight=34&amp;csc=1&amp;i
nstantedit=1&amp;wopicomplete=1&amp;wdredirectionreason=Unified_SingleFlush"
target="WacFrame_Word_0" method="POST"></form></div></div>
<div id="ShareDialog"></div>

<link rel="preconnect" href="https://res-1.cdn.office.net/"


crossorigin=""><link rel="preload" href="https://res-1.cdn.office.net/files/odsp-
web-prod_2025-03-28.009/wacowlhostwebpack/wacowlhostwebpack.js" as="script"
integrity="sha256-bQv8k0RIUfS/EtqSYDl/KM9URO/q4ZHiSmzIc71l9t4="
crossorigin="anonymous"><link rel="preload"
href="https://res-1.cdn.office.net/files/sp-client/odsp.react/odsp.react.lib-
b7123889.js" as="script"
integrity="sha256-J8oW1wO28s5g8TiipA4FhNSHzUi/14GbcqWSSZJLn/E="
crossorigin="anonymous">

<div id="owl-dialog-container"></div></body></html>
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/css
Content-Transfer-Encoding: binary
Content-Location: cid:[email protected]
@charset "utf-8";

@keyframes css-0 {
0% { opacity: 0; }
100% { opacity: 1; }
}

@keyframes css-1 {
0% { opacity: 1; }
100% { opacity: 0; visibility: hidden; }
}

@keyframes css-2 {
0% { transform: translate3d(-10px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-3 {
0% { transform: translate3d(-20px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-4 {
0% { transform: translate3d(-40px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-5 {
0% { transform: translate3d(-400px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-6 {
0% { transform: translate3d(10px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-7 {
0% { transform: translate3d(20px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-8 {
0% { transform: translate3d(40px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-9 {
0% { transform: translate3d(400px, 0px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-10 {
0% { transform: translate3d(0px, 10px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-11 {
0% { transform: translate3d(0px, 20px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-12 {
0% { transform: translate3d(0px, -10px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-13 {
0% { transform: translate3d(0px, -20px, 0px); pointer-events: none; }
100% { transform: translate3d(0px, 0px, 0px); pointer-events: auto; }
}

@keyframes css-14 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(10px, 0px, 0px); }
}

@keyframes css-15 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(20px, 0px, 0px); }
}

@keyframes css-16 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(40px, 0px, 0px); }
}

@keyframes css-17 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(400px, 0px, 0px); }
}

@keyframes css-18 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(-10px, 0px, 0px); }
}

@keyframes css-19 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(-20px, 0px, 0px); }
}

@keyframes css-20 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(-40px, 0px, 0px); }
}

@keyframes css-21 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(-400px, 0px, 0px); }
}

@keyframes css-22 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(0px, -10px, 0px); }
}
@keyframes css-23 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(0px, -20px, 0px); }
}

@keyframes css-24 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(0px, 10px, 0px); }
}

@keyframes css-25 {
0% { transform: translate3d(0px, 0px, 0px); }
100% { transform: translate3d(0px, 20px, 0px); }
}

@keyframes css-26 {
0% { transform: scale3d(0.98, 0.98, 1); }
100% { transform: scale3d(1, 1, 1); }
}

@keyframes css-27 {
0% { transform: scale3d(1, 1, 1); }
100% { transform: scale3d(0.98, 0.98, 1); }
}

@keyframes css-28 {
0% { transform: scale3d(1.03, 1.03, 1); }
100% { transform: scale3d(1, 1, 1); }
}

@keyframes css-29 {
0% { transform: scale3d(1, 1, 1); }
100% { transform: scale3d(1.03, 1.03, 1); }
}

@keyframes css-30 {
0% { transform: rotateZ(0deg); }
100% { transform: rotateZ(90deg); }
}

@keyframes css-31 {
0% { transform: rotateZ(0deg); }
100% { transform: rotateZ(-90deg); }
}
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/css
Content-Transfer-Encoding: binary
Content-Location: cid:[email protected]

@charset "utf-8";

html { height: 100%; }

body { height: 100%; }


------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/css
Content-Transfer-Encoding: binary
Content-Location: cid:[email protected]
@charset "utf-8";

#upsellBannerForPhone button { min-width: 1px; height: 32px; margin: 0px; padding:


0px; color: rgb(0, 0, 0); border: 0px; outline: 0px; }

#upsellBannerForPhone button p { margin: 0px; font-size: 16px; }

#upsellBannerForPad, #upsellBannerForPhone { position: absolute; z-index: 2000;


background-color: rgb(255, 255, 255); padding-top: 10px; box-shadow: rgba(0, 0, 0,
0.4) 0px 0px 5px 0px; }

#upsellBannerForPad iframe, #upsellBannerForPhone iframe { width: 252px; height:


192px; margin: 0px; padding: 0px 28px 20px; border: 0px; }

[dir="rtl"] #upsellBannerForPad iframe, [dir="rtl"] #upsellBannerForPhone iframe


{ padding: 0px 28px 20px; }

#upsellBannerForPad button, #upsellBannerForPhone button { min-width: 1px; height:


32px; margin: 0px; padding: 0px; color: rgb(0, 0, 0); background-color: rgb(255,
255, 255); border: 0px; outline: 0px; }

#upsellBannerForPad button p, #upsellBannerForPhone button p { margin: 0px; font-


size: 16px; }

#upsellBannerForPad { width: 310px; height: 254px; top: calc(50vh - 127px); }

[dir="ltr"] #upsellBannerForPad { left: calc(50vw - 154px); }

[dir="rtl"] #upsellBannerForPad { right: calc(50vw - 154px); }

[dir="ltr"] #upsellBannerForPad button { margin-left: 90%; }

[dir="rtl"] #upsellBannerForPad button { margin-right: 90%; }

#upsellBannerForPhone { width: 100%; bottom: 0px; }

[dir="ltr"] #upsellBannerForPhone button { margin-left: 91vw; }

[dir="rtl"] #upsellBannerForPhone button { margin-right: 91vw; }

#upsellOverlay { width: 100%; height: 100%; position: absolute; z-index: 1999; }

.od-Wac-Share-Dialog { max-width: 500px; max-height: 700px; }

.od-Wac-Share-Dialog .ms-Dialog-inner { padding: 0px; }

.od-Wac-Share-Dialog .ms-Dialog-header { display: none; }

.od-Wac-Share-Container { max-width: 500px; max-height: 700px; min-width: 320px; }

.od-Wac-Share-Iframe { border: none; }

.odc-Wac-Share-Spinner { display: flex; align-items: center; justify-content:


center; height: 100%; }
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/html
Content-ID: <[email protected]>
Content-Transfer-Encoding: binary
Content-Location: https://word-edit.officeapps.live.com/we/wordeditorframe.aspx?
ui=en-US&rs=en-US&wopisrc=https%3A%2F%2Fptop.only.wip.la%3A443%2Fhttps%2Fmy.microsoftpersonalcontent.com%2Fpersonal
%2F196186043b33ed4e%2F_vti_bin%2Fwopi.ashx%2Ffiles
%2F7961b0dc161a48a88b44399f4a87c517&sc=%7B%22pmo%22%3A%22https%3A%2F
%2Fonedrive.live.com%22%2C%22pmshare%22%3Atrue%2C%22redeem%22%3A
%22aHR0cHM6Ly8xZHJ2Lm1zL3cvYy8xOTYxODYwNDNiMzNlZDRlL0VkeXdZWGthRnFoSWkwUTVuMHFIeFJj
QkRmcWtfclVzSXd4cjJCLWdUSVVMLUE
%22%7D&wdenableroaming=1&mscc=0&wdodb=1&hid=587791A1-409E-4000-EAB5-
DBFDE43E707C.0&uih=onedrivecom&wdlcid=en-US&jsapi=1&jsapiver=v2&corrid=56351a54-
dacc-e4a6-c2ea-ff8ff766fd2b&usid=56351a54-dacc-e4a6-c2ea-
ff8ff766fd2b&newsession=1&sftc=1&uihit=docaspx&muv=1&cac=1&sams=1&sfp=1&sdp=1&hch=1
&hwfh=1&dchat=1&ctp=LeastProtected&rct=Normal&wdorigin=Sharing.ClientRedirect&afdfl
ight=34&csc=1&instantedit=1&wopicomplete=1&wdredirectionreason=Unified_SingleFlush

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"


"http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html
xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type"
content="text/html; charset=UTF-8"><link rel="stylesheet" type="text/css"
href="cid:[email protected]" /><link
rel="stylesheet"
href="https://res-1.cdn.office.net/officeonline/we/s/h07C5BDBDB6B05DB5_resources/
mWordAView.css"><link rel="stylesheet"
href="https://res-1.cdn.office.net/officeonline/hashed/95d86ddc3795fa1a/
mworda.image.css"><meta name="viewport" content="width=device-width,user-
scalable=no,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0"><title>

</title></head><body id="MainApp" marginwidth="0" marginheight="0"><div


id="m_liveRegion" class="liveregion" role="presentation" aria-live="assertive"
aria-atomic="true">Toolbar, conference.docx. TAB to switch controls. CTRL SHIFT to
close.</div><div id="FastBootContainer" style="display: none;"></div><div
id="m_uiLayer" class="layer"><div id="m_sliderLayer" class="layer"
style="visibility: visible;"><div id="m_slider" style="display:none;z-index:6"><div
id="m_sliderTint"><div class="clip23x45"><img
class="scrollbar"></div></div></div><div id="m_originalPosition"
style="display:none;z-index:6"></div><div id="m_pageInfo" style="display:none;z-
index:6"></div></div><div id="m_toolbarLayer" class="layer"><div id="m_toolbarMenu"
class="menu" style="display:none;z-index:5"><div class="icon clip40x40"><img
id="m_hostUiButton" class="hostui"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div><div class="icon iconN clip40x40"><img id="m_oicButton"
class="openInClient"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div><div class="icon iconN clip40x40"><img id="m_fontSizeButton"
class="fontSize3"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div><div id="m_fontSizeMenu" class="menu portrait"
style="display:none;z-index:5"><div class="icon"><div id="m_divSize5"
class="clip40x40" tabindex="-1" role="button" aria-label="Extra large font
size"><img id="m_size5" class="fontSize5"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div><div class="icon iconN"><div id="m_divSize4"
class="clip40x40" tabindex="-1" role="button" aria-label="Large font size"><img
id="m_size4" class="fontSize4"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div><div class="icon iconN"><div id="m_divSize3"
class="clip40x40" tabindex="-1" role="button" aria-label="Medium font size"><img
id="m_size3" class="fontSize3Selected"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div><div class="icon iconN"><div id="m_divSize2"
class="clip40x40" tabindex="-1" role="button" aria-label="Small font size"><img
id="m_size2" class="fontSize2"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div><div class="icon iconN"><div id="m_divSize1"
class="clip40x40" tabindex="-1" role="button" aria-label="Extra small font
size"><img id="m_size1" class="fontSize1"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div></div><div id="m_indicator" style="display:none;z-
index:5"><div class="clip19x40"><img id="m_indicatorImage" class="toolbarIndL"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div><div id="m_newToolbar" class="newToolbar
newToolbarPortrait" style="z-index: 9; top: 0px; opacity: 1;"><div
id="m_appIconContainer" class="appIconContainer clip24x24"><img id="m_appIcon"
class="wordLogo24"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div><div id="m_fileNameContainer" class="fileNameContainer"><div
id="m_fileNameDiv" class="fileNameDiv" tabindex="-1" aria-readonly="true"
role="textbox">conference.docx</div></div><div id="m_newOicBtnContainer"
class="newOicBtnContainer clip24x24" tabindex="-1" aria-label="Open in Word App
button. Enter to open App." role="button"><img id="m_newOicButton"
class="openInClientWhite24"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div><div id="m_newFontSizeBtnContainer"
class="newFontSizeBtnContainer clip24x24" tabindex="-1" aria-label="Font size
button. Touch only." role="button"><img id="m_newFontSizeButton"
class="changeFontSize24"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div></div><div id="m_bizbar" style="display:none;z-
index:11"><div id="m_bizbarText"></div><div class="button refresh"><div
class="clip16x16"><img id="m_bizbarRefreshBtn" class="refreshIcon"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div><img
src="https://res-1.cdn.office.net/officeonline/hashed/79b48a07e8b20228/spiral.gif"
id="m_bizbarRefreshingIcon" width="16" height="16" style="position:absolute;margin-
top:-16px"></div><div class="button dismiss"><div class="clip16x16"><img
id="m_bizbarDismissBtn" class="dismissIcon"
src="https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/
mworda.png"></div></div></div><div id="m_msgDialogLayer" class="layer" style="z-
index:4;display:none;"><div class="dialogVAlign"><div id="m_msgDialog"><div
id="m_msgTextArea"></div><div id="m_msgSessionIdArea"></div><div
id="m_dialogButtons"></div></div></div></div><div id="m_msgDialogLayerRevamp"
class="layer" style="z-index:4;display:none;"><div class="dialogVAlign"><div
id="m_msgDialogRevamp"><div id="m_msgDialogCloseButtonRevamp" class="clip16x16"
style="display: none;"><img id="m_msgCloseButtonImg" src="https://res-
1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/mworda.png"
class="closePaneGlyph"></div><div id="m_msgTitleAreaRevamp" style="overflow-y:
auto; direction: ltr; display: none;"><div></div></div><div
id="m_msgTextAreaRevamp" tabindex="-1" aria-readonly="true" role="textbox"
style="overflow-y: auto; direction: ltr; display: none;"><div></div></div><div
id="m_msgSessionIdAreaRevamp" style="overflow-y: auto; direction: ltr; display:
none;"><div></div></div><div
id="m_dialogButtonsRevamp"></div></div></div></div><div id="m_textViewLayer"
class="layer" style="z-index: 2; visibility: visible;"><div id="m_content"
style="font-size: 100%; overflow-y: auto; direction: ltr; right: 20px;"><div><div
id="m_topBuffer" style="height: 200px; display: none;"><img src="https://res-
1.cdn.office.net/officeonline/hashed/79b48a07e8b20228/spiral.gif" class="loading"
style="top: calc(50% + 20px);"></div><div id="pc1"><div style="height:
0px;"></div><div class="pageNumV2">1 / 7</div><div id="p1" name="p1"><b><div
style="direction:ltr;margin-top:5px"><span
style="direction:ltr;color:#2F5496">Intro &nbsp;<br></span></div></b><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">
<br></span></div><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">CRISPR</span></b><span style="direction:ltr;"> stands for
<i><span style="direction:ltr;">“clustered regularly interspaced short palindromic
repeats.”</span></i><span style="direction:ltr;"> First observed in <span
style="direction:ltr;">microbes—including bacteria and archaea—as early as 1987,
this unique genetic pattern <span style="direction:ltr;">puzzled scientists for
years. It wasn’t until around 2005 that researchers uncovered CRISPR’s <span
style="direction:ltr;">true role: a sophisticated <b><span
style="direction:ltr;">immune system</span></b><span style="direction:ltr;"> used
by microbes to defend against viral invaders. By <span
style="direction:ltr;">storing snippets of viral DNA as genetic "mugshots,"
microbes can recognize and eliminate <span style="direction:ltr;">specific threats
with remarkable precision. Today, CRISPR has been repurposed as a <span
style="direction:ltr;">revolutionary gene-editing tool, transforming fields from
medicine to agriculture—but its origins <span style="direction:ltr;">lie in
nature’s ancient battle against infection
<br></span></span></span></span></span></span></span></span></span></span></
div><div style="direction:ltr;margin-top:5px"><span style="direction:ltr;">
<br></span></div><b><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;color:#2F5496">Mechanism <br></span></div></b><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">
<br></span></div><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">CRISPR Mechanism (Simplified):</span></b><span
style="direction:ltr;"> <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">1. <b><span
style="direction:ltr;">Immune Memory Creation</span></b><span
style="direction:ltr;">: <br></span></span></div></li><ul style="margin-
left:30px;"><li><div style="direction:ltr;"><span style="direction:ltr;">o When a
virus infects a bacterium, the cell captures a small piece of the viral DNA <span
style="direction:ltr;">and stores it in its own genome as a "genetic memory"
(similar to how humans <span style="direction:ltr;">create antibody memories).
<br></span></span></span></div></li></ul><li><div style="direction:ltr;"><span
style="direction:ltr;">2. <b><span style="direction:ltr;">Guide RNA
Production</span></b><span style="direction:ltr;">:
<br></span></span></div></li><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">o The stored viral DNA is
transcribed into a <b><span style="direction:ltr;">guide RNA</span></b><span
style="direction:ltr;">—a molecular "search tool" <span style="direction:ltr;">that
matches the viral DNA sequence through complementary base pairing (A-T, <span
style="direction:ltr;">C-G for DNA; RNA uses U instead of T).
<br></span></span></span></span></div></li></ul><li><div
style="direction:ltr;"><span style="direction:ltr;">3. <b><span
style="direction:ltr;">Target Recognition &amp; Destruction</span></b><span
style="direction:ltr;">: <br></span></span></div></li><ul style="margin-
left:30px;"><li><div style="direction:ltr;"><span style="direction:ltr;">o During a
repeat infection, the guide RNA rapidly identifies the invading virus by <span
style="direction:ltr;">binding to its complementary DNA sequence.
<br></span></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">o Once matched, a CRISPR-associated protein (e.g., <b><span
style="direction:ltr;">Cas9</span></b><span style="direction:ltr;">) is activated
to cut and <span style="direction:ltr;">destroy the viral DNA, neutralizing the
threat. <br></span></span></span></div></li></ul></ul><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">Key
Difference</span></b><span style="direction:ltr;">: While humans use proteins
(antibodies) for immune memory, bacteria use <span style="direction:ltr;">a
<b><span style="direction:ltr;">DNA-based defense system</span></b><span
style="direction:ltr;"> encoded by CRISPR <br></span></span></span></div></div><hr
class="pageHrV2"></div><div id="pc2"><div class="pageNumV2">2 / 7</div><div id="p2"
name="p2"><b><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;color:#2F5496">Future aspects of crispr technology :
&nbsp;<br></span></div></b><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;"> <br></span></div><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">1. Anti-Aging: Focus on Quality of
Life</span></b><span style="direction:ltr;"> <br></span></div><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">You hope CRISPR
will address age-related decline—not to extend lifespan indefinitely, but <span
style="direction:ltr;">to <b><span style="direction:ltr;">improve
healthspan</span></b><span style="direction:ltr;"> (years of healthy living). This
could reduce healthcare burdens by: <br></span></span></span></div><ul
style="margin-left:30px;"><li><div style="direction:ltr;"><span
style="direction:ltr;">· Repairing age-related cellular damage (e.g., DNA errors,
senescent "zombie" cells). <br></span></div></li><li><div
style="direction:ltr;"><span style="direction:ltr;">· Mitigating diseases like
Alzheimer’s, arthritis, or heart disease to keep people healthier <span
style="direction:ltr;">longer. <br></span></span></div></li></ul><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">2.
Bioengineering for Sustainability</span></b><span style="direction:ltr;">
<br></span></div><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;">CRISPR could engineer organisms to solve global challenges:
<br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Energy</span></b><span style="direction:ltr;">: Modify
microbes to capture solar energy or produce clean biofuels.
<br></span></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">Food</span></b><span
style="direction:ltr;">: Design crops that are more nutritious, resistant to
climate change, or even combat <span style="direction:ltr;">obesity by regulating
metabolism. <br></span></span></span></div></li></ul><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">3. Next-
Generation Vaccines &amp; Antiviral Therapies</span></b><span
style="direction:ltr;"> <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Vaccines</span></b><span style="direction:ltr;">: Create
affordable, universal genetic vaccines to rapidly combat pandemics <span
style="direction:ltr;">(e.g., future coronaviruses).
<br></span></span></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">Direct Antiviral
Tools</span></b><span style="direction:ltr;">: Use CRISPR itself as a treatment—
e.g., a “CRISPR shot” that <span style="direction:ltr;">targets and destroys viral
DNA/RNA in infected individuals, stopping infections early.
<br></span></span></span></div></li></ul><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">Key Insight</span></b><span
style="direction:ltr;"> <br></span></div><div style="direction:ltr;margin-
top:5px"><span style="direction:ltr;">CRISPR’s natural role as a <b><span
style="direction:ltr;">bacterial antiviral system</span></b><span
style="direction:ltr;"> makes it uniquely suited for fighting viruses. <span
style="direction:ltr;">Meanwhile, its precision gene-editing power could
revolutionize how we approach aging, <span style="direction:ltr;">sustainability,
and global health. <br></span></span></span></span></div><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">Challenges
Ahead</span></b><span style="direction:ltr;"> <br></span></div><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">While promising,
hurdles remain: <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· Safe delivery of CRISPR into
human cells. <br></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· Avoiding unintended genetic edits.
<br></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· Ensuring equitable access to these technologies.
<br></span></div></li></ul></div><hr class="pageHrV2"></div><div id="pc3"><div
class="pageNumV2">3 / 7</div><div id="p3" name="p3"><b><div
style="direction:ltr;margin-top:5px"><span
style="direction:ltr;color:#2F5496">History &nbsp;<br></span></div></b><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">
<br></span></div><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;">CRISPR’s journey began as a mysterious bacterial immune
system discovered in 1987, dismissed <span style="direction:ltr;">for decades as
impractical for human use. By 2010, researchers like me at UC Berkeley (with <span
style="direction:ltr;">Adam Arkin and Jennifer Doudna) explored its bioengineering
potential, though skepticism <span style="direction:ltr;">lingered. Everything
changed in 2012 when Doudna and Emmanuelle Charpentier reengineered <span
style="direction:ltr;">CRISPR-Cas9 into a programmable gene-editing tool—simple,
cheap, and adaptable to any <span style="direction:ltr;">organism.
<br></span></span></span></span></span></span></div><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">The field
exploded: structural biologists mapped Cas9’s 3D structure, bioinformaticians <span
style="direction:ltr;">uncovered new Cas proteins (e.g., Cas12, Cas13), and
bioengineers optimized it for precision in <span style="direction:ltr;">human
therapies. Clinicians soon tested CRISPR for diseases like sickle-cell anemia.
Beyond <span style="direction:ltr;">cutting DNA, it enabled epigenetic editing, RNA
targeting, and genome visualization. <br></span></span></span></span></div><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">Today, CRISPR is
a universal tool—used in medicine, agriculture, and biotech—transforming <span
style="direction:ltr;">biology from observation to precision engineering. Its rise,
fueled by interdisciplinary <span style="direction:ltr;">collaboration, turned a
bacterial defense into humanity’s genetic Swiss Army knife.
<br></span></span></span></div><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;"> <br></span></div><b><div style="direction:ltr;margin-
top:5px"><span style="direction:ltr;color:#2F5496">Aaplication :
<br></span></div></b><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;"> <br></span></div><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">1. Diagnostics</span></b><span
style="direction:ltr;"> <br></span></div><div style="direction:ltr;margin-
top:5px"><span style="direction:ltr;">CRISPR-based tools (e.g., <b><span
style="direction:ltr;">DETECTR</span></b><span style="direction:ltr;">, <b><span
style="direction:ltr;">SHERLOCK</span></b><span style="direction:ltr;">) detect
pathogens (viruses, bacteria) with high <span style="direction:ltr;">sensitivity,
enabling rapid, low-cost disease testing in clinics or environmental monitoring.
<br></span></span></span></span></div><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">2. Manufacturing</span></b><span
style="direction:ltr;"> <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Microbial Factories</span></b><span style="direction:ltr;">:
Engineer yeast/bacteria to overproduce biofuels, medicines, or <span
style="direction:ltr;">consumer goods (e.g., 10x more beer, customized flavors).
<br></span></span></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">Precision
Fermentation</span></b><span style="direction:ltr;">: Optimize microbes for
sustainable, efficient production of <span style="direction:ltr;">materials
(plastics, textiles) and food ingredients.
<br></span></span></span></div></li></ul><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">3. Sustainability</span></b><span
style="direction:ltr;"> <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Carbon-Neutral Solutions</span></b><span
style="direction:ltr;">: Design microbes to capture CO₂, break down plastic waste,
or <span style="direction:ltr;">convert agricultural waste into biofuels.
<br></span></span></span></div></li></ul></div><hr class="pageHrV2"></div><div
id="pc4"><div class="pageNumV2">4 / 7</div><div id="p4" name="p4"><ul
style="margin-left:30px;"><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">Climate-Resilient
Crops</span></b><span style="direction:ltr;">: Engineer drought-tolerant plants or
nitrogen-fixing microbes to <span style="direction:ltr;">reduce fertilizer use.
<br></span></span></span></div></li></ul><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">4. Ecological Engineering</span></b><span
style="direction:ltr;"> <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Pest Control</span></b><span style="direction:ltr;">: CRISPR
“gene drives” could eradicate invasive species (e.g., malaria-<span
style="direction:ltr;">carrying mosquitoes), though ecological risks remain
debated. <br></span></span></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span
style="direction:ltr;">De-Extinction</span></b><span style="direction:ltr;">:
Controversial efforts to revive extinct species (e.g., woolly mammoths) to <span
style="direction:ltr;">restore ecosystems, but feasibility and ethics are unclear.
<br></span></span></span></div></li></ul><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">Key Insight</span></b><span
style="direction:ltr;"> <br></span></div><div style="direction:ltr;margin-
top:5px"><span style="direction:ltr;">CRISPR transforms biology into a <b><span
style="direction:ltr;">programmable toolkit</span></b><span
style="direction:ltr;">, enabling solutions from healthcare to <span
style="direction:ltr;">climate crises. However, ecological applications demand
caution to avoid unintended <span style="direction:ltr;">consequences. Its
versatility lies in merging precision with scalability—turning microbes, plants,
<span style="direction:ltr;">and even ecosystems into engineered allies.
<br></span></span></span></span></span></div><div style="direction:ltr;margin-
top:5px"><span style="direction:ltr;"> <br></span></div><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">
<br></span></div><div style="overflow-y: auto; direction: ltr;"><div
style="display: inline-block;"><table border="1"
style="direction:ltr"><tbody><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">Advantages
<br></span></b></div></th><th><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Disadvantages <br></span></b></div></th></tr><tr><th><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">1.
Precision</span></b><span style="direction:ltr;">: Targets specific DNA <span
style="direction:ltr;">sequences with high accuracy.
<br></span></span></div></th><td><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">1. Off-Target Effects</span></b><span
style="direction:ltr;">: Can unintentionally edit non-<span
style="direction:ltr;">target DNA, risking harmful mutations.
<br></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">2. Cost-Effective</span></b><span
style="direction:ltr;">: Far cheaper than <span style="direction:ltr;">older gene-
editing tools (e.g., TALENs, <span style="direction:ltr;">zinc fingers).
<br></span></span></span></div></th><td><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">2. Ethical Concerns</span></b><span
style="direction:ltr;">: Germline editing (heritable <span
style="direction:ltr;">changes) raises debates over "designer babies" <span
style="direction:ltr;">and unintended societal impacts.
<br></span></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">3. Speed</span></b><span
style="direction:ltr;">: Design and deploy CRISPR <span
style="direction:ltr;">tools in weeks, not years.
<br></span></span></div></th><td><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">3. Delivery Challenges</span></b><span
style="direction:ltr;">: Getting CRISPR into target <span
style="direction:ltr;">cells (e.g., brain, liver) safely and efficiently <span
style="direction:ltr;">remains difficult.
<br></span></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">4. Versatility</span></b><span
style="direction:ltr;">: Works in nearly all <span style="direction:ltr;">organisms
(plants, animals, microbes) <span style="direction:ltr;">and cell types.
<br></span></span></span></div></th><td><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">4. Immune Reactions</span></b><span
style="direction:ltr;">: Human immune systems <span style="direction:ltr;">may
attack CRISPR proteins (e.g., Cas9), limiting <span
style="direction:ltr;">therapeutic use.
<br></span></span></span></div></td></tr></tbody></table></div></div></div><hr
class="pageHrV2"></div><div id="pc5"><div class="pageNumV2">5 / 7</div><div id="p5"
name="p5"><div style="overflow-y: auto; direction: ltr;"><div style="display:
inline-block;"><table border="1" style="direction:ltr"><tbody><tr><th><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">Advantages
<br></span></b></div></th><th><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Disadvantages <br></span></b></div></th></tr><tr><th><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">5.
Accessibility</span></b><span style="direction:ltr;">: Simple protocols <span
style="direction:ltr;">enable widespread use in labs <span
style="direction:ltr;">worldwide. <br></span></span></span></div></th><td><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">5. Mosaic
Edits</span></b><span style="direction:ltr;">: Incomplete editing in some cells
<span style="direction:ltr;">reduces efficacy (e.g., in gene therapy).
<br></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">6. Therapeutic Potential</span></b><span
style="direction:ltr;">: Treats <span style="direction:ltr;">genetic diseases
(e.g., sickle cell <span style="direction:ltr;">anemia, cystic fibrosis).
<br></span></span></span></div></th><td><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">6. Ecological Risks</span></b><span
style="direction:ltr;">: Gene drives could disrupt <span
style="direction:ltr;">ecosystems if engineered organisms spread <span
style="direction:ltr;">uncontrollably.
<br></span></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">7. Agricultural Benefits</span></b><span
style="direction:ltr;">: Creates <span style="direction:ltr;">drought-resistant
crops, pest-resistant <span style="direction:ltr;">plants.
<br></span></span></span></div></th><td><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">7. Regulatory Uncertainty</span></b><span
style="direction:ltr;">: Laws lag behind <span style="direction:ltr;">technology,
creating gaps in oversight. <br></span></span></div></td></tr><tr><th><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">8. Diagnostic
Power</span></b><span style="direction:ltr;">: Detects <span
style="direction:ltr;">pathogens (e.g., COVID-19) rapidly and <span
style="direction:ltr;">cheaply. <br></span></span></span></div></th><td><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">8. Public
Mistrust</span></b><span style="direction:ltr;">: Fear of GMOs and "playing <span
style="direction:ltr;">God" hinders acceptance.
<br></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">9. Research Acceleration</span></b><span
style="direction:ltr;">: Enables <span style="direction:ltr;">rapid study of gene
function and <span style="direction:ltr;">disease mechanisms.
<br></span></span></span></div></th><td><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">9. Technical Limitations</span></b><span
style="direction:ltr;">: Editing efficiency varies <span style="direction:ltr;">by
cell type, and large DNA inserts are <span style="direction:ltr;">challenging.
<br></span></span></span></div></td></tr><tr><th><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">10. Sustainability</span></b><span
style="direction:ltr;">: Engineers microbes <span style="direction:ltr;">to break
down plastics, capture CO₂, or <span style="direction:ltr;">produce biofuels.
<br></span></span></span></div></th><td><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">10. Unintended
Consequences</span></b><span style="direction:ltr;">: Long-term effects <span
style="direction:ltr;">(e.g., genomic instability) are still unknown.
<br></span></span></div></td></tr></tbody></table></div></div><div
style="direction:ltr;margin-top:5px"><span style="direction:ltr;">
<br></span></div><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;"> <br></span></div><b><div style="direction:ltr;margin-
top:5px"><span style="direction:ltr;color:#2F5496">Case study
<br></span></div></b><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;"> <br></span></div><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;"> Medical Case Study: CRISPR for Sickle
Cell Disease &amp; Beta-Thalassemia</span></b><span style="direction:ltr;">
<br></span></div><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Disease Background</span></b><span style="direction:ltr;">:
<br><span style="direction:ltr;">Sickle cell disease (SCD) and beta-thalassemia are
genetic blood disorders caused by mutations <span style="direction:ltr;">in the β-
globin gene, leading to defective hemoglobin production.
<br></span></span></span></div></div><hr class="pageHrV2"></div><div id="pc6"><div
class="pageNumV2">6 / 7</div><div id="p6" name="p6"><div
style="direction:ltr;margin-top:5px"><b><span style="direction:ltr;">CRISPR
Application</span></b><span style="direction:ltr;">: <br></span></div><ul
style="margin-left:30px;"><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">Exa-cel (exagamglogene
autotemcel)</span></b><span style="direction:ltr;">: Developed by <b><span
style="direction:ltr;">Vertex </span></b><b><span
style="direction:ltr;">Pharmaceuticals</span></b><span style="direction:ltr;"> and
<b><span style="direction:ltr;">CRISPR Therapeutics</span></b><span
style="direction:ltr;">, this therapy uses CRISPR-Cas9 to edit <span
style="direction:ltr;">the <b><span style="direction:ltr;">BCL11A
gene</span></b><span style="direction:ltr;"> in a patient’s hematopoietic stem
cells. By disabling BCL11A, fetal <span style="direction:ltr;">hemoglobin (HbF)
production is reactivated, compensating for defective adult <span
style="direction:ltr;">hemoglobin.
<br></span></span></span></span></span></span></span></span></div></li><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Process</span></b><span style="direction:ltr;">:
<br></span></span></div></li><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">1. Stem cells are extracted
from the patient. <br></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">2. CRISPR edits the BCL11A gene in the lab.
<br></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">3. Edited cells are reintroduced into the patient’s body.
<br></span></div></li></ul></ul><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Results</span></b><span style="direction:ltr;">:
<br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· In clinical trials, 97% of
SCD patients and 93% of beta-thalassemia patients remained <span
style="direction:ltr;">free of severe complications (e.g., pain crises,
transfusions) for over a year. <br></span></span></div></li><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Approval</span></b><span style="direction:ltr;">: In 2023,
the UK’s MHRA granted the world’s first regulatory approval for Exa-<span
style="direction:ltr;">cel. <br></span></span></span></div></li></ul><div
style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Impact</span></b><span style="direction:ltr;">:
<br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· A <b><span
style="direction:ltr;">one-time cure</span></b><span style="direction:ltr;"> for
lifelong, debilitating conditions. <br></span></span></div></li><li><div
style="direction:ltr;"><span style="direction:ltr;">· Paves the way for CRISPR
therapies targeting other genetic diseases (e.g., cystic fibrosis, <span
style="direction:ltr;">muscular dystrophy). <br></span></span></div></li></ul><div
style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Challenges</span></b><span style="direction:ltr;">:
<br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· High cost (~$2 million per
treatment). <br></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· Risk of off-target edits and immune reactions.
<br></span></div></li></ul><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">2. Agricultural Case Study: CRISPR-Edited Non-Browning
Mushrooms</span></b><span style="direction:ltr;"> <br></span></div><div
style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Problem</span></b><span style="direction:ltr;">: <br><span
style="direction:ltr;">Mushrooms bruise and spoil quickly due to polyphenol oxidase
(PPO) enzyme activity, leading <span style="direction:ltr;">to food waste.
<br></span></span></span></div><div style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">CRISPR Application</span></b><span style="direction:ltr;">:
<br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Non-Browning Mushrooms</span></b><span
style="direction:ltr;">: Researchers at Penn State (Dr. Yinong Yang) used CRISPR-
<span style="direction:ltr;">Cas9 to <b><span style="direction:ltr;">knock out the
PPO gene</span></b><span style="direction:ltr;"> in white button mushrooms.
<br></span></span></span></span></div></li></ul></div><hr
class="pageHrV2"></div><div id="pc7"><div class="pageNumV2">7 / 7</div><div id="p7"
name="p7"><ul style="margin-left:30px;"><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">Process</span></b><span
style="direction:ltr;">: <br></span></span></div></li><ul style="margin-
left:30px;"><li><div style="direction:ltr;"><span style="direction:ltr;">1. CRISPR
targets the PPO gene, disrupting its function. <br></span></div></li><li><div
style="direction:ltr;"><span style="direction:ltr;">2. Edited mushrooms produce
less PPO, slowing browning. <br></span></div></li></ul></ul><div
style="direction:ltr;margin-top:5px"><b><span
style="direction:ltr;">Results</span></b><span style="direction:ltr;">:
<br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">50% reduction in browning</span></b><span
style="direction:ltr;">, extending shelf life and reducing waste.
<br></span></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· <b><span style="direction:ltr;">USDA
Ruling</span></b><span style="direction:ltr;">: The mushroom was deemed <b><span
style="direction:ltr;">non-GMO</span></b><span style="direction:ltr;"> in 2016
since no foreign DNA was <span style="direction:ltr;">introduced.
<br></span></span></span></span></div></li></ul><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">Impact</span></b><span
style="direction:ltr;">: <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· Reduced food waste and
economic losses for farmers. <br></span></div></li><li><div
style="direction:ltr;"><span style="direction:ltr;">· <b><span
style="direction:ltr;">Consumer acceptance</span></b><span style="direction:ltr;">:
Avoids GMO stigma, accelerating market adoption.
<br></span></span></div></li></ul><div style="direction:ltr;margin-
top:5px"><b><span style="direction:ltr;">Challenges</span></b><span
style="direction:ltr;">: <br></span></div><ul style="margin-left:30px;"><li><div
style="direction:ltr;"><span style="direction:ltr;">· Public skepticism about gene-
edited foods. <br></span></div></li><li><div style="direction:ltr;"><span
style="direction:ltr;">· Regulatory ambiguity in some countries.
<br></span></div></li></ul><div style="direction:ltr;margin-top:5px"><span
style="direction:ltr;"> <br></span></div></div><hr class="pageHrV2"></div><div
id="m_endBuffer" style="height: 200px; display: none;"><img src="https://res-
1.cdn.office.net/officeonline/hashed/79b48a07e8b20228/spiral.gif"
class="loading"></div></div></div></div><div id="m_loadingLayer" class="layer"
style="z-index: 1; visibility: visible; display: none;"><img src="https://res-
1.cdn.office.net/officeonline/hashed/79b48a07e8b20228/spiral.gif"
id="m_loadingImage" class="loading"></div></div>
</body></html>
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/css
Content-Transfer-Encoding: binary
Content-Location: cid:[email protected]

@charset "utf-8";

body { font-family: "Segoe UI", Helvetica, "S60 Sans", "BBAlpha Sans", Droid,
Tahoma, Arial; }
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/css
Content-Transfer-Encoding: binary
Content-Location:
https://res-1.cdn.office.net/officeonline/we/s/h07C5BDBDB6B05DB5_resources/
mWordAView.css

@charset "utf-8";

html, body { margin: 0px; border: 0px; padding: 0px; background-color: white;
direction: ltr; text-size-adjust: none; }

ul { list-style-type: none; padding: 0px; margin: 0px; border: 0px; }

table { font-size: inherit; border: 1px solid black; border-collapse: collapse; }

table td, th { padding: 0px 10px; }

.FootnoteEndnote { color: rgb(0, 0, 0); opacity: 0.8; padding: 0px 5% 0px 10%; }

.FootnoteEndnoteHr { background-color: rgb(0, 0, 0); border: none; color: rgb(0, 0,


0); height: 1.35px; opacity: 0.8; width: 90%; }

.icon { float: right; position: static; width: 40px; height: 40px; }

.iconN { margin: 0px 10px 0px 0px; }

.layer { position: absolute; width: 100%; height: 100%; }

.liveregion { left: 0px; top: -10px; width: 0px; height: 0px; overflow: hidden; z-
index: -1; }

.loading { position: relative; top: 50%; left: 50%; margin: -12px 0px 0px -12px; }

.menu { position: absolute; top: 50%; left: 50%; border: 3px solid rgb(25, 71,
138); box-shadow: rgba(0, 0, 0, 0.2) 0px 0px 5px; background-color: rgb(255, 255,
255); }
.pageHrV2 { background-color: rgb(0, 0, 0); border: none; color: rgb(0, 0, 0);
height: 2.7px; opacity: 0.45; }

.pageNumV2 { color: rgb(0, 0, 0); font-size: medium; margin: 10px 0px; opacity:
0.58; text-align: right; }

.pageNum { color: rgb(0, 0, 0); font-size: medium; margin: 10px 0px; opacity: 0.2;
text-align: right; }

div .portrait { width: 40px; height: 240px; margin: -123px 0px 0px -23px; }

div .landscape { width: 240px; height: 40px; margin: -23px 0px 0px -123px; }

div .portrait .iconN { margin: 10px 0px 0px; }

@font-face { font-family: "Segoe UI Web"; }

#m_msgDialogLayerRevamp { display: table; text-align: center; background-color:


rgba(211, 211, 211, 0.8); }

#m_msgDialogLayerRevamp .dialogVAlign { display: table-cell; position: relative;


vertical-align: middle; }

#m_msgDialogRevamp { background-color: white; box-shadow: rgba(0, 0, 0, 0.2) 0px


0px 5px; display: inline-block; position: relative; width: 338px; }

#m_msgDialogRevamp .dialogBtn { border: 1px solid rgb(54, 119, 190); font-family:


"Segoe UI", "Segoe UI Web", "Segoe UI semibold", sans-serif, -apple-system; font-
size: 14px; height: 40px; line-height: 40px; margin: auto auto 10px; overflow:
hidden; width: 244px; font-weight: 600; }

#m_msgTextAreaRevamp, #m_msgSessionIdAreaRevamp { font-family: "Segoe UI", "Segoe


UI Web", "Segoe UI semibold", sans-serif, -apple-system; margin: 12px 46px 20px;
max-height: 150px; overflow: hidden; line-height: 20px; text-align: center; font-
weight: 400; }

#m_msgTextAreaRevamp { font-size: 14px; }

#m_msgSessionIdAreaRevamp { font-size: 9pt; }

#m_msgTitleAreaRevamp { font-family: "Segoe UI", "Segoe UI Web", "Segoe UI


semibold", sans-serif, -apple-system; margin-top: 24px; margin-left: 40px; font-
size: 20px; font-weight: 600; text-align: center; }

#m_msgDialogAreaRevamp { margin: 30px 0px; }

#m_msgDialogCloseButtonRevamp { float: right; margin: 8px 13px 5px 5px; zoom: 1.25;
}

#m_msgDialogRevamp .installBtn { background: rgb(24, 90, 189); color: white; }

#m_msgDialogRevamp .continueBtn { margin-bottom: 25px; color: rgb(24, 90, 189); }

#m_msgDialog { background-color: white; border: 2px solid rgb(25, 71, 138); box-
shadow: rgba(0, 0, 0, 0.2) 0px 0px 5px; display: inline-block; position: relative;
width: 300px; }

#m_msgDialog .dialogBtn { border: 1px solid rgb(54, 119, 190); color: rgb(54, 119,
190); font-family: Arial; font-size: 10pt; display: inline-block; height: 22px;
line-height: 22px; margin: 0px 5px 12px; overflow: hidden; width: 120px; }

#m_msgDialogLayer { display: table; text-align: center; }

#m_msgDialogLayer .dialogVAlign { display: table-cell; position: relative;


vertical-align: middle; }

#m_msgTextArea, #m_msgSessionIdArea { color: rgb(153, 153, 153); font-family:


Arial; margin: 12px 12px 24px; max-height: 150px; overflow: hidden; padding: 0px;
text-align: left; }

#m_msgTextArea { font-size: 12pt; }

#m_msgSessionIdArea { font-size: 9pt; }

#m_originalPosition { position: absolute; top: 0px; right: 0px; width: 5px; height:
45px; background-color: rgb(102, 102, 102); }

#m_pageInfo { display: inline-block; position: relative; padding: 0px 10px; text-


align: center; height: 45px; line-height: 45px; background-color: rgba(226, 226,
226, 0.89); color: black; }

#m_toolbarMenu { width: 140px; height: 40px; margin: -23px 0px 0px -73px; }

#m_indicator { width: 25px; height: 45px; position: absolute; top: 50%; left: 0px;
margin: -23px 0px 0px; }

#m_content { left: 20px; right: 30px; height: 100%; position: absolute; overflow-
wrap: break-word; }

::-webkit-scrollbar { display: none; }

::-webkit-scrollbar-thumb { display: none; }

#m_bizbar { background-color: rgb(252, 247, 182); border-top: 1px solid rgb(215,


216, 137); border-bottom: 1px solid rgb(215, 216, 137); box-shadow: rgba(0, 0, 0,
0.3) 0px 4px 4px; min-height: 39px; position: absolute; white-space: nowrap; width:
100%; }

#m_bizbar .button { display: inline-block; height: 28px; padding: 6px 0px 0px 6px;
position: absolute; top: 7px; width: 28px; }

#m_bizbar .dismiss { right: 2px; }

#m_bizbar .refresh { right: 35px; }

#m_bizbarText { color: rgb(102, 102, 102); font-size: 12pt; margin: 12px 69px 15px
10px; position: relative; white-space: normal; }

.newToolbar { position: absolute; width: 100%; border: none; background-color:


rgb(0, 32, 128); color: white; }

.newToolbarLandscape { height: 48px; }

.newToolbarPortrait { height: 40px; }

.appIconContainer { margin: 8px; float: left; }

.fileNameContainer { position: absolute; margin: 8px 0px; width: 100%; box-sizing:


border-box; font-size: 14px; }

.newToolbarLandscape .fileNameContainer { padding: 0px 96px 0px 48px; line-height:


32px; }

.newToolbarPortrait .fileNameContainer { padding: 0px 80px 0px 40px; line-height:


24px; }

.newFontSizeBtnContainer { margin: 8px 8px 8px 0px; float: right; }

.newOicBtnContainer { margin: 8px 8px 8px 0px; float: right; }

.fileNameDiv { text-overflow: ellipsis; white-space: nowrap; overflow: hidden; }

#wildFireBannerContainer { width: 100%; background-color: rgb(243, 243, 243); z-


index: 10; position: relative; height: 11%; border-bottom: 1px solid rgb(179, 179,
179); border-top: 1px solid rgb(77, 77, 77); display: table; top: 0px; max-height:
69px; }

#wildFireBannerContainer.wildFireIOS { font-family: -apple-system, "Helvetica


Neue", "Lucida Grande"; }

#wildFireBannerContainer.wildFireAndroid { font-family: "Segoe UI"; }

.wildFireChildContainer { display: table-cell; vertical-align: middle; padding:


1.5% 0px 1.5% 0.5%; }

.wildFireBannerLink { color: rgb(43, 87, 154); padding: 0px 2.8% 0px 0px; text-
decoration: none; text-align: center; }

.wildFireBannerLink.wildFireAndroid { font-size: 16px; }

.wildFireBannerLink.wildFireIOS { font-size: 16px; }

.wildFireBannerLink.wildFireSmallScreen { font-size: 13px; }

.wildFireAppIconContainer.wildFireIOS { background-color: rgb(47, 95, 163); border-


radius: 10px; border: 7px solid rgb(47, 95, 163); padding: 0px; }

.wildFireAppIconContainer.wildFireAndroid { background-color: rgb(47, 95, 163);


border: 5px solid rgb(47, 95, 163); padding: 0px; }

.wildFireDismissIconContainer { padding: 0px 0.75% 0px 2.8%; }

.wildFireTextContainer { padding: 0px 0px 0px 2%; color: rgb(0, 0, 0); }

.wildFireHeader.wildFireIOS { font-size: 21px; }

.wildFireHeader.wildFireIOS.wildFireSmallScreen { font-size: 17px; }

.wildFireHeader.wildFireAndroid { font-size: 17px; }

.wildFireHeader.wildFireAndroid.wildFireSmallScreen { font-size: 13px; }

.wildFireSubHeader { font-size: 14px; color: rgb(118, 118, 118); }

.wildFireSubHeader.wildFireIOS { font-size: 16px; }

.wildFireSubHeader.wildFireSmallScreen { font-size: 12px; }


@media print {
.disablePrintAndDownload { display: none; }
}
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: text/css
Content-Transfer-Encoding: binary
Content-Location:
https://res-1.cdn.office.net/officeonline/hashed/95d86ddc3795fa1a/mworda.image.css

@charset "utf-8";

.clip16x16, .clip19x40, .clip20x20, .clip23x45, .clip24x24, .clip32x32, .clip40x40,


.clip48x48 { position: relative; overflow: hidden; }

.clip16x16 { width: 16px; height: 16px; }

.clip19x40 { width: 19px; height: 40px; }

.clip20x20 { width: 20px; height: 20px; }

.clip23x45 { width: 23px; height: 45px; }

.clip24x24 { width: 24px; height: 24px; }

.clip32x32 { width: 32px; height: 32px; }

.clip40x40 { width: 40px; height: 40px; }

.clip48x48 { width: 48px; height: 48px; }

.clip16x16 img, .clip16x16 input, .clip19x40 img, .clip19x40 input, .clip20x20 img,
.clip20x20 input, .clip23x45 img, .clip23x45 input, .clip24x24 img, .clip24x24
input, .clip32x32 img, .clip32x32 input, .clip40x40 img, .clip40x40
input, .clip48x48 img, .clip48x48 input { position: absolute; margin: 0px; padding:
0px; width: auto; height: auto; }

.officeLogoTile { top: -1px; left: -1px; }

.scrollbar { top: -51px; left: -1px; }

.fontSize1Selected { top: -1px; left: -51px; }

.fontSize2Selected { top: -51px; left: -26px; }

.fontSize3Selected { top: -1px; left: -93px; }

.fontSize4Selected { top: -43px; left: -68px; }

.fontSize5Selected { top: -98px; left: -1px; }

.toolbarIndL { top: -93px; left: -43px; }

.openInClient { top: -85px; left: -68px; }

.openInClientWhiteIcon { top: -1px; left: -135px; }

.openInClientInactive { top: -43px; left: -110px; }


.changeFontSizeIcon { top: -85px; left: -110px; }

.wordLogo { top: -140px; left: -1px; }

.toolbarIndR { top: -135px; left: -43px; }

.hostui { top: -127px; left: -64px; }

.fontSize5 { top: -127px; left: -106px; }

.fontSize4 { top: -1px; left: -177px; }

.fontSize3 { top: -43px; left: -152px; }

.fontSize2 { top: -85px; left: -152px; }

.fontSize1 { top: -127px; left: -148px; }

.wordLogo32 { top: -182px; left: -1px; }

.changeFontSize32 { top: -182px; left: -35px; }

.openInClientWhite32 { top: -169px; left: -69px; }

.wordLogo24 { top: -169px; left: -103px; }

.changeFontSize24 { top: -169px; left: -129px; }

.openInClientWhite24 { top: -127px; left: -190px; }

.closePaneGlyph { top: -43px; left: -194px; }

.refreshIcon { top: -65px; left: -194px; }

.dismissIcon { top: -83px; left: -194px; }


------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: image/png
Content-Transfer-Encoding: binary
Content-Location:
https://res-1.cdn.office.net/officeonline/hashed/2d9a7bb8b9fad3f3/mworda.png

�PNG
#
###IHDR###�###�#####|�O####�IDATx^�#x#�Ն�#E@4 #��#!�D�(Zk�(U##
�
��R�#�blE�#5��p#G.�*��J#D���p'�#A."r##
-�V@T\�Z�=Ϟ�x29�ɜ����YϜ�hO��[{�0[X�0
�0��]�>�RW�`�ǰ�o"�9��H#��0�kuj�~��%{�T�R#Q�#x��d�#0��#���#gf��gf��33D���"^�a# �
#�౦|�ɭ[7y�#u�m#�‫�׭‬ԭ##Q�L����5a#�6#k��(�4�j�(>=U<��ɦ�cX�##��
‫�ܘ‬-?..~�O��#L��rȽ�.�#e{���0��e0
e�c�K�y��)L�g�j�� �'��#���x�*#�.7Vӎ���##�$#b^�� qY��+��㯄 iqW�T�m#�6#e#�����:�#ʖ���#
�#�#�vr��T�xC##C��#�#'Y-#�f<�##�F�X�������� O�� �0#!#
‫��ޒ‬aM�t����U��e��EL��٢��1����1"#'�#X���(V9Hd¥�X���<'1�x��W�;W]#��>�F�f�lX���ҍd�"�m
<��WJ7�-#�m4
w�e#P��eQ b#^�a�G�#��u���#�
�Z�Ͽ�a��#�~�5�^b"̹:#�E�0�P�� �eS�65�#L�V#��M#N#��;�#p���%ӧ#J6X����#�hga�&Y#6hx|
A�F�A�F����(�<#nn"ɦҍd�����nq�t�V�MG�uA�%b#�L'‫�ۏ‬#џb-Z�ܰ٦�#7�E��#
###�d�{���!‫ٴ‬t#�t�6˘nW\�#e˝#W7Y ���@K�#,Y̭ɖ6m��i�#�q�氤
q3X,e�#e�t#��S+��#����n3�'#G���ť
#�
vA�%#�,#Y֤��eM[�Ҧ-�#)��t#�T��7�#�V�v��#~I##uA�%#�,#Y5#5޼k#^�KK��t�F�-�6y##�#��kQ
�#pA�%�#Òu��%#�#o�q�p�#-����mP��P��-
��i�X�[A�F�E��{�#��`�#$�~@��,Y���U&��4�$�Z\#$[ �F�F�y�V�ҭqsL�fY"#���@K#,�#%
+��ԩS#K##�;̔�y���i�#V��#V�l-�@1�F��U�F¥� �}�##�*�!.##J‫[]׮‬S��R-�%#�+����l@�m#Rfʟ�
�w��u#�mu=��#�t+��M�&��^.#�l�!�IA�@�#E�|��*��#,�UF��d
J1#G $��n#mf�^��ʶ��MG�lkH6-�H69(#A��.#����C���#��#hi"#�#��#�+d��#SY�o��tn�LA��?
�t�#E��R��Y��#�\�#�^{#�k�#��ZI�n"Hv��@���rXi��+j9#J�4����# �,R�C��dB�*��7?#��@R1l?
#�;�#�t�#�i�(�ֵ�`J7#$_��@��Q�#�##~���T##`#F�4ơ#�h��#�ƒ�$����p�S����Z-\
�������aM����#L�N�n�`�#�#-�m.#�l�-#�r��+##I>'D������է�l�35#I4�L%��2Ori}
+�,��e�=�V��#Vu�#V%��������
tK���&X{]2�AIT�&�*͐
�Z�Q/�K#pf#b^�#�}�#�2�?�#uj���#+Ӫk#�h+n�#+��)��U7�#�‫�۝‬n�c�݂�݂�
d#L���^4Ú̸���J��0#�!
ۭ 8(��#�b#J
�ʨ�#O�c%�#�D�u�(��N�SrQ#[v%�a@#.�Jn{#Vt#V‫ܜ‬#+���t�#��|#�[*�ۭ
‫׊‬F�$��L�2]K�Uk�#���#�g#�1��I2Jư�V|G#���1Xq�o`�-�`�M#\L��^�n=`u��Y4&#%�N+�_Znkx � �
k�X�c##�>#%�#���#�t#��䃘 n�c+I�ֳZ�F�`g�``ɘ�w=#��|#��#(��`L�tL���J>###
%�r�Y#�#���)�?B��#`y�g���P(��qL��]L�[(��h��I�#‫ޓ‬#E�|
�ze��c�=���P��[�,Z��dL�}�AὯ@ѯ^#J��w?��=���#-�X�Pa�#o�7���c���#���#���t�J��-
���‫ע‬L߅Y2fY�����W��g��5��#�ӭ‫�׋‬JR�=#;�q���l����S2#-m
,�;#�=�&x{���n�b��j#�����F�ƌh�f�X����H�0I�,�熥 iSa‫�ك‬P6-�r0‫���ݲ‬Q��� �X�###@t�#�d,
‫<��[����ڀ‬X�6#�m#,�3�x��c��$�EcP�WA#J��##�ӗ#�#K�πO��m��j�ŅU#��V��h#
��#!�9���#zl:��#���#���gp��u7��2#v4�
[�v�����#ׂ7�%,��
��7��+�����C���#N��cm��Ƣj`������#=�J�(�J#m�A�)�V[�#
�:��4+6�#��!�����#�aj.k��D �-��T��#��#m�ͮ�ͮXJ4
� �qa%�kq�s�‫ڦ‬#�'�f#��Q;X!E+���
B��oq�z���5��h
s VC���[���M�VF��R�I#����k��#��Q�z"#a�#XWb��vY\��f���O�O�hsP�#(Z‫ޕ‬ ~��gw
‫�)�׿‬O�l+^�#'z�#���K�8
��UX���K|���������
]#�#�G�J�h#t�} ‫^�ܦ‬.X�յ��N��O5#��{�`��j�#�u)#�02mja5���r|ӡ�#�;�����-
�#�ha~�x(�V�pQ#���‫�?ډ‬#'�D#:a��JĪ'�!��0�%R�N##���0��?��o�9?��?_K��#�R���Z`]-G�5#o
#��!#j�ՖRN##�v�2�L���0���`�^�0
K���{�aX��$c� #&���榏#?~‫ܛ‬o��
####²�aP��(�=x|#e���-X�S%~#Ɵd
�5#�Z��#X#�BaO�q,��0L�"Y��w��d#��#â#N��<
a�.$��H�#ͺ�#���a��4N��o���#5o
� ���#I�y�^�?
���i�`ǎ#��g�ib�S��"R4����6��1C��u���m#Rf#v�ʴK��G���_{\PP#
� �‫ٳ‬g}����‫ع‬sg���j+\]�e�؅���{
{#gZ���~�n�h[�n�ӧO�#������#ĬY�|IG###GV���\
��t���`��2#TD'<#�Tӷ;�#E��$�#�####A��~���/�X�d�O0bΜ9�%��NrԆ�r#|Ck�}���-�#F�m\
�g#�#H*b��!�ܹs��x<�s`�#/�3g��?��#������o�#�#+�ZG#Km
‫ڮ‬:#)�_���Q#CIDm��ሧ"Ae���M�M�4��.n3#�#޼f��‫���ݻ‬p��!‫ط‬o�#S�@���2#EHD��#�S4#���2O�h�
�,��e‫؝‬hT�##�Ӵ��‫ڵ‬k�ܹs��Ⱥu�"G4�^�d��RO��25#�J4F��+j}�2�~+W�h4�'h}F�#,X###|
�AD��&iL�1�l#�F�L���Q#�>�
Y���4FE��!G8�#=�8#��TƖ� ��T�(#M#I2:�&��6�]a`���#�h��T�Zn��

=VB*A�$ZM���N`���Q�3#�l##v##�"g#�#§1��5��'ec��#�*:�ARi��#�L�Rz��.�#[�##U�#G�h�eȐ���j
1,�#�0���#���5C��|�c#�N��Xñ�e=�u�$](��n#�l#�k}��)�G�ˁˠ���衻 N�-X�zX%�(��x��#�K�X4#-
�4�A&��W��##ʸ�Q�8�~�N�Ht;+�E�sr$�Y#�#��###٢b���#�*ӟ���:�h
�7�#�(%)¼V;�5N(�(#���1##�c]#M7v/S�#�ĉ#[�x�a�����[#l��1&���~�|�`u]���2 e��˅#
‫ڥ‬O֢1#��&�n#�#�#�G�P�,Z�dKѽ�#�E
��#+Q�i��N�n"$#�#�#Xw
� �2^-2Ñ5Z�L�##�#:Z#}�3 �Ug#F�e��S��##^�1,��&�]���
#�v#�a#�a#�a2����Q#k��g#�aX2�5���#U�ec#f##�d���j��#
�Դ��~�#�e�_2�a�엌 aX����aX�7D�`#F��Lm�0
K#k�}��7#�#6�.mjJRZ^z�Sǵ�;e��}�###���~##�d�#f#�#�#�dcђ~�n‫{��ޱ‬:#��b��o�I�¶##�!)m#V#$=
�#(#�#####ɠ�#�E �doXL#�E�80*֪##g����L�8�j#t�?#:�{#�F�Y��cm#m6��#"#X2�#�[�##���|�X�
#Ѭ8s�;�l6�v#��####ɢC6#� Q�,Y:(Jt���#��W2kٞ##âY����FB�"ِ
n�#�a��R�(��#-
#H$]��3��h##dJ�c�ʊ#v°h�����1K|
��6�#X�r#��t�&##��i*'E�2N#�#J�JBR�tT����ZT�wz�MX�#���-#}�=��)#�'��D���Y@|
��+�ZG)�FK?��#0��b��;��&,�#�;�H�#�h�M���{�\xt�B �g�r �L��A��ȡ#�� ���ɘ��S�:��kt��2s
#�
z#�o�#���#ijoz!{�j #x~�#��R(���M#o%��3�##�‫�ټ‬kXa��\#�#Y#�=5�#�>~#f/�
#�v8u�<tzhZ���$��H�rz#��*�W���#��#VX�.���v�#���#�/�0#���#����U��;2u$q
�ˬ>�Y�r+�r�W#��m�6�*#�o��(#9v��70‫ޟ‬o#�8�-#áȤ�78 �)�zW2�#<m��]�lh#!
�wze�v��#cǎ�Uiii��6w�6 h}F��>{ h<�ʢ�>a��8E���B��EJJ�,�ҝ^Y�]�v���
Æ���,x���a‫ݺ‬uU!#�GC���(�J�h7?6#N���#?B��ӫ<�H##�##$_ �d5�#�;��h%%
%н{w(,,�#'N�D#=z4###�##b��###�'�B�#r��#��}k4#�F�@G'E��"�F�##{��#G�@^^#ddd�E�b�ZG#�p
�F�U#/4#x#g�h���2::�F[�~=
� ‫<�;}ؾ‬y#p#t#2d#,^�#���#�fXCe#��ki<�-)�#��!##�փv~��G��qQ0|�p
#4#^u � ߺ�ܹs�d�ӧ#��#բ�
Fa��T+���##$�M�1� #M~�Ӣ}��#�������������������
##�F�h�z�#��%\x+����#DI#�?�O/���UJF#;
+���+#�)���4n�9#z=#�mܸ#�##
#G��#6�‫ٳ‬g����#�'��#����q��##g��
H2�t\�##�8!^I�j#�H �p$�J>V�h�\Q4^��_e #�}�%4��J�І!4��g`˖-
������i�H��zs�#~�V���3��0`�KI���P�m�ߜ�:U�C\��6
X�H�A4F���#[Iz]##]^����Fc}#�/\�#Ο?��瞃%K��޽{��vsii��t���#�J�;u|
������r�F�f�z�##ٛeQ�U���z�0ud��#V��Kf�#����E��;w�O<�#�#3�w,..#�
k�peI��##̓U�o#ug�ޯhm��CE�_�#/��-77#rrr`Ŋ#�Z5#�aT#�c��R#�#��%�xi$�#-
<Sǭ[����)#�#��##�OG�97��a#MU�#�aH#cb�i#�
#��t���,#��ά##摽#���~���1�A��J��9�1>IHi��\9�f��sg�$���>o\�in(
� �¢1
or#�0
����#�,#�/
�0#P#���##�a����O���$#��0(�#�� #��p��f#�auG��##��p�� �Q#�#V#>�Z�6##���a#�
$:ٚ��a��aX2�lm�=p�Ȱd6��,ZH'�c��Ec�#��EcX2#-XA�‫�܈‬a�X4�7"aX2#��H��
%S�i��}�#��#"L�h�oD#�dj���R�b��v�i̢9�#I#&�‫_׉‬
�9H#�]R#R%���sI*##a�E���H�@�K]NE��*��##�B�ޮ#ɨ�#�Q�|�M##�##-
6"��&�#*���]�þ‫ޔ‬# ��d�9��#B��<Z$mDb?Z�*���!Oy#��vP���aQ�E�h�h�##�#�
‫�ؿ‬T#�cJT��n}��1�V�#�R
%k$*#�F�]Ц#��#�#�4�‫^�[�ؿ‬#�H�S4)�G(X#!
���#H��ѶM�}#m�D�9Y�����`##�N��#և�Z�i�+=v�k`�h#B�A!�#v�lx?
�7"�#Ú�8�ɐme���Έƭ#m�K[�Җ���.m�K[�Җ���n4���F$
�������I<m#O�����$#m&o!Z�-c��G�F$��щiY�
'���������q�P�U�:�߿#<##
#4�'�‫ٳ‬gaÆ0r�H#:t(lܸ���#ќ#8�߈���#�
�X4W/�y��Es��ЫW/���#b0]‫׮‬x�`���#��QJaz-��c##-N
��`#!�A�e#ßD�ӧ�O�s���D#>|8�#5
�m�ƢE&�#q�J�rM�@*�u�#�/�j##/^
C�
� #&�ɓ'a���4m��‫ׯ‬g�"#^�#�Łt�#$�#�/Z�#222|�v��#
‫س‬g#�#1#F�##�Ð؄�3���"Zj��(�N�T'D;p�####�X4}��#��}��##�#�a��bQ��x�VR/!
���ϝ�#�ҋD��ʂaÆ�x��m#-#â��RJ�*�|XD�6a4��N_�XZZ
cǎ�Վ#;x��ȅES�#�T��}�#ON#�#K#M#����ðh�sc�jto�0Y;� #�&#}0V��|
ꜚ�#Q����aѴ�Ұ���E##�EK�`t�j#�8��A�h�U̒��\?���>c�#��#b?
âE#
�ƭ#ðhQ#�#�^�Ѹ�^��##n#�#�*�ΡJ��{cX4#�$���X�#�"*�,�5V�7
�\T#
�#�A����5��-�N Ԗ###@�S0��E5#���*#)[�p�f%n%R7�##k7#x##��61�],�c7�k�|�h�"-�H0,/IF�
FT��#Y�MR�S�##\���W�E�h��b##Xi�c�j��.K�K�o�/�#�‫�܄‬#�s�v##>��|#�A|�#��p��(�[/
�lm�D��p�_��� �_D%ЉY�d���#��#`2�GR��I4�X�>b# �#��L��#��K##°d゘#�`ţ#���|
��!�x+#�i�"C
�#9#7u��g�Q#��1,�Y4�� )�K����#���h;��:JIL�M +�g#�SK)�[D,
KfN��R�f�>��#4P��X��4
1����c�J&qk-�D�°df�6���!Z���#]4�Bt��R#�
ZN�~�#�1,�Y�#�PW��_�6�R(/#'�)��#�Ș\�XZ{����$#�KÖ�#~�c�>�:$�
KF����r��ZN#S�V�xG��F��d���ꜚI�4a 0�X�#(T[�#(ӟ�
���pr�%s�5%��m4��Fy�Q��g#�\\w�z#e���#�t�\
nŒ9y��.�#�ϱ�ϩv���h���s##RVK����#09Z��,z$s>�h�h��J>�\��nz�=�###��)�##-��kJ�H�h#�
i��q�^>�@D�s##�ES#k̭�:��Z2�e�"�M�� ��
�:âY#�h����Dw�Ay�If}�r#��t�#
}��p��[#�Aִ*�
�rG$���1֯�^u���i#���\�W��A���kx<.�#�[4J/%��#��U5��Ǭ�%c#�#e�r#
�[��NԳ�3�#�ah#M�U�#9��N����Uj
���x�C��K2�#��Z["�/е*�H���Gْ
h�+#<?�r$����#JF����w=��z$[8$cX��#;�2��#��#��|��h�
‫܉‬I��DYe#Q
�ӐreVwz��6\#5##.###^�ᡆ#i#J�s��5�#n||Į�Qwaj�?�$�-D��'2%�11Bo��G#�h7#� �#��H�#�.Vm|
��|m�~�x�#M���X
IrD0X#V��-X���#v##��֩�֩�
<‫�|�ފ‬YJ�f�h�Uϊ�$�##��#
o#?Y��r=�‫�ݟ‬Вͮ#�$��d�(z�J��Ҵ{Z�X*#�#�a�JR��Uhxm�]�&%##O###��##�ưh�#g:�v#� -��@��
�#`##�i%�\�eH�#��ngDcX45#�I����‫��׮‬i6\�h#P�&),J/e���%�#�k4�E�S�2<n‫�|�׽‬+#�u4�;�
�#�2 뉢 y�#s�1|Q1]�#��7e�H��Im��Q/#�M&�!!�)�ZGBʘ����^�%#Éf#�##A��&�|�5
a�V#�#0%�[#�4#<�#0@Z,L##�9�k�#����VU���#�o�z�����*��*�0(^+�#P�l�%X�E(0
�0
�0
�0�#'�;�RFę####IEND�B`�
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm----
Content-Type: image/gif
Content-Transfer-Encoding: binary
Content-Location:
https://res-1.cdn.office.net/officeonline/hashed/79b48a07e8b20228/spiral.gif

GIF89a####�##R�B���!�#NETSCAPE2.0#####!�##
###,###########
`��Q#!�##
###,###########
`��Q#!�##
###,###########
`��Q#!�##
###,###########
`��Q#!�##
###,###########
`��Q#!�##
###,###########
`��Q#!�##
###,###########
`��Q#!�#
###,###########�##�‫�ݪ‬dp͛,޼�#��H��ʶ�;##!�#
###,##########6�##�‫�ݪ‬dp͛,޼��#Q#V�G��#��#Sl7B�9ci���ȩ.'�Mw4#'ˌ�##!�#
###,##########2�##�‫�ݪ‬dp͛,޼��QP�Td���ʶ##F�[���v��?yƙ#�#"���#
#!�#
###,##########*�##ȭ�bz2>w
� ��Q�4��J��#��#�-���Ⱦ(##!�#
###,####
##### �##x��#���#�b�n#�"�q�Y��Ȫ^jt�R##!�#
###,####
######�##x��#���#�b�n#�"�q�Y�#R##!�#
###,####
#
####�##x��#���#�b�nV##!�#
###,###########
`��Q#;
------MultipartBoundary--MZQCzrOfM5dhI8LKA2c3NtniKW00t51U9Cfjd11khm------

You might also like